Kety Huberman

8.1k total citations
13 papers, 847 citations indexed

About

Kety Huberman is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Kety Huberman has authored 13 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Kety Huberman's work include Cancer Genomics and Diagnostics (6 papers), Cancer therapeutics and mechanisms (3 papers) and Lung Cancer Research Studies (3 papers). Kety Huberman is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Cancer therapeutics and mechanisms (3 papers) and Lung Cancer Research Studies (3 papers). Kety Huberman collaborates with scholars based in United States, United Kingdom and Spain. Kety Huberman's co-authors include Adriana Heguy, Agnès Viale, Barry S. Taylor, Anuradha Gopalan, Brett S. Carver, Melanie Bernstein, Peter T. Scardino, Rajmohan Murali, Andrew J. Vickers and Nikolaus Schultz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Kety Huberman

11 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kety Huberman United States	9	364	302	289	278	141	13	847
Sam Leung Canada	8	332 0.9×	238 0.8×	244 0.8×	214 0.8×	66 0.5×	13	808
Mari K. Halle Norway	19	360 1.0×	246 0.8×	222 0.8×	143 0.5×	68 0.5×	52	916
Evangelos Bournakis Greece	15	272 0.7×	267 0.9×	153 0.5×	160 0.6×	33 0.2×	35	621
Sarah E. Russell Australia	5	662 1.8×	385 1.3×	188 0.7×	197 0.7×	39 0.3×	5	1.0k
Tsutomu Imai Japan	8	595 1.6×	330 1.1×	316 1.1×	61 0.2×	33 0.2×	15	900
Ingvild L. Tangen Norway	17	257 0.7×	180 0.6×	145 0.5×	102 0.4×	36 0.3×	26	684
Dzifa Y. Duose United States	16	261 0.7×	170 0.6×	239 0.8×	195 0.7×	25 0.2×	45	698
Megumi Yanokura Japan	24	785 2.2×	236 0.8×	650 2.2×	90 0.3×	123 0.9×	57	1.4k
Joema Felipe Lima United States	10	264 0.7×	242 0.8×	214 0.7×	76 0.3×	25 0.2×	15	535

Countries citing papers authored by Kety Huberman

Since Specialization

Citations

This map shows the geographic impact of Kety Huberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kety Huberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kety Huberman more than expected).

Fields of papers citing papers by Kety Huberman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kety Huberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kety Huberman. The network helps show where Kety Huberman may publish in the future.

Co-authorship network of co-authors of Kety Huberman

This figure shows the co-authorship network connecting the top 25 collaborators of Kety Huberman. A scholar is included among the top collaborators of Kety Huberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kety Huberman. Kety Huberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Stewart, Caitlin M., Sonya Parpart-Li, James R. White, et al.. (2025). Clonal hematopoiesis detection by simultaneous assessment of peripheral blood mononuclear cells, blood plasma, and saliva. Journal of Clinical Investigation. 135(16).

Kotecha, Ritesh R., Erika Gedvilaite, Andrea Knežević, et al.. (2022). Matched Molecular Profiling of Cell-Free DNA and Tumor Tissue in Patients With Advanced Clear Cell Renal Cell Carcinoma. JCO Precision Oncology. 6(6). e2200012–e2200012. 8 indexed citations

Marass, Francesco, Julie L. Yang, Caitlin M. Stewart, et al.. (2020). Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience. Cancer Medicine. 9(17). 6093–6101. 35 indexed citations

Narayan, Raja R., Debra A. Goldman, Mithat Gönen, et al.. (2019). Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer. Annals of Surgical Oncology. 26(6). 1824–1832. 23 indexed citations

García-Rendueles, María E.R., Julio C. Ricarte‐Filho, Brian R. Untch, et al.. (2015). NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition. Cancer Discovery. 5(11). 1178–1193. 99 indexed citations

Schultheis, Anne M., Charlotte K.Y. Ng, Maria Rosaria De Filippo, et al.. (2015). Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas. JNCI Journal of the National Cancer Institute. 108(6). djv427–djv427. 151 indexed citations

Hsieh, James J., David Chen, Patricia Wang, et al.. (2015). Identification of efficacy biomarkers in a large metastatic renal cell carcinoma (mRCC) cohort through next generation sequencing (NGS): Results from RECORD-3.. Journal of Clinical Oncology. 33(15_suppl). 4509–4509. 22 indexed citations

Zauderer, Marjorie G., A. Drilon, Kyuichi Kadota, et al.. (2014). Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase. Lung Cancer. 86(2). 237–240. 45 indexed citations

Hieronymus, Haley, Nikolaus Schultz, Anuradha Gopalan, et al.. (2014). Copy number alteration burden predicts prostate cancer relapse. Proceedings of the National Academy of Sciences. 111(30). 11139–11144. 231 indexed citations

10.

Schatz, Jonathan H., Steven M. Horwitz, Matthew A. Lunning, et al.. (2013). Next-Generation Sequencing Suggests Complex, Heterogeneous Pathogenesis In Peripheral T-Cell Lymphoma Unspecified. Blood. 122(21). 843–843. 2 indexed citations

11.

Pietanza, M. Catherine, Kyuichi Kadota, Kety Huberman, et al.. (2012). Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker. Clinical Cancer Research. 18(4). 1138–1145. 122 indexed citations

12.

Coffey, Kelly, Timothy J. Blackburn, Susan Cook, et al.. (2012). Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer. PLoS ONE. 7(10). e45539–e45539. 109 indexed citations

13.

Drilon, Alexander, Kety Huberman, Camelia S. Sima, et al.. (2012). 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial.. Journal of Clinical Oncology. 30(15_suppl). 7052–7052.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact